Cargando…

Common Genetic Risk for Melanoma Encourages Preventive Behavior Change

There is currently great interest in using genetic risk estimates for common disease in personalized healthcare. Here we assess melanoma risk-related preventive behavioral change in the context of the Coriell Personalized Medicine Collaborative (CPMC). As part of on-going reporting activities within...

Descripción completa

Detalles Bibliográficos
Autores principales: Diseati, Lori, Scheinfeldt, Laura B., Kasper, Rachel S., Zhaoyang, Ruixue, Gharani, Neda, Schmidlen, Tara J., Gordon, Erynn S., Sessions, Cecili K., Delaney, Susan K., Jarvis, Joseph P., Gerry, Norman, Christman, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384058/
https://www.ncbi.nlm.nih.gov/pubmed/25695399
http://dx.doi.org/10.3390/jpm5010036
Descripción
Sumario:There is currently great interest in using genetic risk estimates for common disease in personalized healthcare. Here we assess melanoma risk-related preventive behavioral change in the context of the Coriell Personalized Medicine Collaborative (CPMC). As part of on-going reporting activities within the project, participants received a personalized risk assessment including information related to their own self-reported family history of melanoma and a genetic risk variant showing a moderate effect size (1.7, 3.0 respectively for heterozygous and homozygous individuals). Participants who opted to view their report were sent an optional outcome survey assessing risk perception and behavioral change in the months that followed. Participants that report family history risk, genetic risk, or both risk factors for melanoma were significantly more likely to increase skin cancer preventive behaviors when compared to participants with neither risk factor (ORs = 2.04, 2.79, 4.06 and p-values = 0.02, 2.86 × 10(−5), 4.67 × 10(−5), respectively), and we found the relationship between risk information and behavior to be partially mediated by anxiety. Genomic risk assessments appear to encourage positive behavioral change in a manner that is complementary to family history risk information and therefore may represent a useful addition to standard of care for melanoma prevention.